OTCMKTS:NWCI - Newcardio Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started $0.0040 0.00 (0.00 %) (As of 03/22/2019 09:59 AM ET)Previous Close$0.0040Today's Range$0.0015 - $0.004052-Week Range$0.0006 - $0.0140Volume1,750 shsAverage Volume6,772 shsMarket Capitalization$163,240.00P/E RatioN/ADividend YieldN/ABeta7.58 ProfileDiscussionChartEarningsHeadlinesSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email NewCardio, Inc., a cardiac diagnostic and services company, focuses on the research, development, and commercialization of proprietary software platform technology solutions for the non-invasive diagnosis and monitoring of cardiovascular disease (CVD), as well as the cardiac safety assessment of drugs under development. The company's technology platform provides real-time and 3-D analysis of the heart's electrical activity as detected at the body surface by standard 12-lead electrocardiogram (ECG) electrodes. Its developing products include QTinno, an automated cardiac safety solution that replaces the manual and/or semi-automated methodologies with algorithms that automatically measure, analyze, and report on the ECGs collected; and CardioBip, a mobile ECG transtelephonic system comprising a mobile ECG recording and transmitting device, and a Web enabled software which receives, processes, and analyzes the data. The company is also developing my3KG, a software application to provide a method to assess cardiac electrical activity in time and space. NewCardio, Inc. was founded in 2004 and is based in Branchburg, New Jersey. Receive NWCI News and Ratings via Email Sign-up to receive the latest news and ratings for NWCI and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange OTCMKTS Industry Electromedical equipment Sub-IndustryN/A SectorMedical Current SymbolOTCMKTS:NWCI Previous Symbol CUSIPN/A CIKN/A Webwww.newcardio.com Phone510-774-1969Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/APrice-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AProfitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous Employees10 Outstanding Shares40,810,000Market Cap$163,240.00 Next Earnings DateN/A OptionableNot Optionable Newcardio (OTCMKTS:NWCI) Frequently Asked Questions What is Newcardio's stock symbol? Newcardio trades on the OTCMKTS under the ticker symbol "NWCI." Has Newcardio been receiving favorable news coverage? Press coverage about NWCI stock has been trending somewhat positive this week, according to InfoTrie. The research firm identifies negative and positive media coverage by analyzing more than six thousand news and blog sources in real time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Newcardio earned a daily sentiment score of 0.8 on InfoTrie's scale. They also gave headlines about the company a news buzz of 7.0 out of 10, indicating that recent media coverage is likely to have an impact on the company's share price in the next few days. Who are some of Newcardio's key competitors? Some companies that are related to Newcardio include Guided Therapeutics (GTHP), Magna-Lab (MAGAA), Echo Therapeutics (ECTE), 21st North (ULGX), IMRIS (IMRSQ), Nexeon Medsystems (NXNND), SpectraScience (SCIE) and Vision Sciences (CGNT). What other stocks do shareholders of Newcardio own? Based on aggregate information from My MarketBeat watchlists, some companies that other Newcardio investors own include Largo Resources (LGO), SRG Graphite (SRG), Bedrocan Cannabis (BED), Crestwood Equity Partners (CEQP), Pieris Pharmaceuticals (PIRS), Citius Pharmaceuticals (CTXR), Crispr Therapeutics (CRSP), Trulieve Cannabis (TCNNF), Krystal Biotech (KRYS) and SinglePoint (SING). Who are Newcardio's key executives? Newcardio's management team includes the folowing people: Dr. Jess Emery Jones M.D., CEO & Director (Age 40)Mr. Greg Sadowski, Chief Operating Officer How do I buy shares of Newcardio? Shares of NWCI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is Newcardio's stock price today? One share of NWCI stock can currently be purchased for approximately $0.0040. How big of a company is Newcardio? Newcardio has a market capitalization of $163,240.00. Newcardio employs 10 workers across the globe. What is Newcardio's official website? The official website for Newcardio is http://www.newcardio.com. How can I contact Newcardio? Newcardio's mailing address is 2350 MISSION COLLEGE BLVD. #1175, SANTA CLARA CA, 95054. The company can be reached via phone at 510-774-1969 or via email at [email protected] MarketBeat Community Rating for Newcardio (OTCMKTS NWCI)Community Ranking: 2.6 out of 5 ( )Outperform Votes: 22 (Vote Outperform)Underperform Votes: 21 (Vote Underperform)Total Votes: 43MarketBeat's community ratings are surveys of what our community members think about Newcardio and other stocks. Vote "Outperform" if you believe NWCI will outperform the S&P 500 over the long term. Vote "Underperform" if you believe NWCI will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 3/22/2019 by MarketBeat.com StaffFeatured Article: What is the S&P 500 Index?